A Phase 1/2a, Single- and Multiple-dose Escalation Study of KRRO-110

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2024
The purpose of this first-in human (FIH) study is to assess the safety, tolerability, and pharmacokinetics (PK) of single and multiple doses of KRRO-110 in both healthy adult participants and in clinically stable patients with Alpha-1 antitrypsin deficiency (AATD).
Epistemonikos ID: e3ea5d8e0de69b0fc1573bce858bb69d49972963
First added on: Dec 01, 2024